TrialJournal of neuro-oncology2015
A phase II trial of tamoxifen and bortezomib in patients with recurrent malignant gliomas.
Yazmín Odia et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
22 papers cite it
this paperpooled ittrialcites it
TrialJournal of neuro-oncology2015
Yazmín Odia et al.PubMed ↗Publisher ↗
No numbers read from the abstract.